Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by AIDS Malignancy Consortium
National Cancer Institute (NCI)
The EMMES Corporation
University of Arkansas
Information provided by (Responsible Party):
AIDS Malignancy Consortium Identifier:
First received: February 7, 2014
Last updated: September 1, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)